Safety and Efficacy of Nontuberculous Mycobacteria Treatment among Elderly Patients.

Conclusion: Age may not be an obstacle for receiving the benefits of the treatment of NTM disease with a precise evaluation of patient's comorbidities. Furthermore, elderly patients without heart disease and ADL disability may have better rate of continuing the NTM treatment. The current study suggested that selecting standard regimens to treat pulmonary NTM is important for elderly patients. PMID: 33023085 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33023085?dopt=Abstract

Source: Medicina (Kaunas) - October 2, 2020 Category: Universities & Medical Training Authors: Uchida Y, Terada J, Homma T, Mikuni H, Hirai K, Saito H, Honda R, Sagara H Tags: Medicina (Kaunas) Source Type: research